NPPA regulates some retail medicines | Fusion - WeRIndia

NPPA regulates some retail medicines

NPPA regulates some retail medicines

Hypertension and diabetes are common nowadays. Many young people are also using medicines for these lifestyle diseases. Hence, to keep these drugs available to common people, the National Pharmaceutical Pricing Authority (NPPA) fixed the retail prices of these medicines.

Apart from these medicines, NPPA fixed the retail prices of 84 medicines used for several diseases. These drug formulations are used in the treatment of many health issues, including high blood pressure, Type 2 diabetes, inflammation, gastrointestinal disorders, triglyceride levels to control stroke and heart attack, and cardiovascular diseases.

NPPA is a government regulatory agency. It controls the prices of drugs in India. It fixes and revises the prices of various drug formulations and controlled bulk drugs to keep them in control to make sure that they are easily available to people.

Besides, it monitors the prices of decontrolled drugs as well and keeps them at a reasonable price.


NPPA issued a notification in this regard asking all pharma companies to adhere to the fixed prices. Or else they have to pay the overcharged price amount with interest to the customers. All retailers and dealers are directed to display the price list and supplementary price list.

Prices of some retail medicines that have been fixed are as mentioned below:

The price of a tablet of Atorvastatin and Fenofibrate tablet has been fixed at ₹13.87. The tablet is used in the treatment of heart diseases and diabetes.

Similarly, the price of Rosuvastatin Aspirin and Clopidogrel capsule has been fixed at ₹13.91. The price of a tablet of Paracetamol and Caffeine has been fixed at ₹2.88.

The price of a single tablet of Voglibose and (SR) Metformin Hydrochloride has been fixed at ₹10.47. The GST has not included the price.

NPPA asked the drug manufacturers to submit a price list through the database management system. Besides, they have to provide a copy to the state drug controller.

Image from Pxhere (Free for commercial use / CC0 Public Domain)


Image Reference: https://pxhere.com/en/photo/1163947

Leave a Reply

Your email address will not be published.